Structure-function analysis of a phage display-derived peptide that binds to insulin-like growth factor binding protein 1

被引:37
作者
Skelton, NJ
Chen, YM
Dubree, N
Quan, C
Jackson, DY
Cochran, A
Zobel, K
Deshayes, K
Baca, M
Pisabarro, MT
Lowman, HB
机构
[1] Genentech Inc, Dept Prot Engn, S San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Bioorgan Chem, S San Francisco, CA 94080 USA
关键词
D O I
10.1021/bi0103866
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Highly structured, peptide antagonists of the interaction between insulin-like growth factor 1 (IGF-I) and IGF binding protein 1 (IGFBP-1) have recently been discovered by phage display of naive peptide libraries [Lowman, H. B., et al. (1998) Biochemistry 37, 8870-8878]. We now report a detailed analysis of the features of this turn-helix peptide motif that are necessary for IGFBP-1 binding and structural integrity. Further rounds of phage randomization indicate the importance of residues contributing to a hydrophobic patch on one face of the helix. Alanine-scanning substitutions confirm that the hydrophobic residues are necessary for binding. However, structural analysis by NMR spectroscopy indicates that some of these analogues are less well folded. Structured, high-affinity analogues that lack the disulfide bond were prepared by introducing a covalent constraint between side chains at positions i and i + 7 or i + 8 within the helix. Analogues based on this scaffold demonstrate that a helical conformation is present in the bound state, and that hydrophobic side chains in this helix, and residues immediately preceding it, interact with IGFBP-1. By comparison of alanine scanning data for IGF-I and the turn-helix peptide, we propose a model for common surface features of these molecules that recognize IGFBP-1.
引用
收藏
页码:8487 / 8498
页数:12
相关论文
共 40 条
[1]   Discovery of a novel non-peptide somatostatin agonist with SST4 selectivity [J].
Ankersen, M ;
Crider, M ;
Liu, SQ ;
Ho, B ;
Andersen, HS ;
Stidsen, C .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1998, 120 (07) :1368-1373
[2]   Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities [J].
Baxter, RC .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 278 (06) :E967-E976
[3]   CLINICAL USES OF INSULIN-LIKE GROWTH-FACTOR-I [J].
BONDY, CA ;
UNDERWOOD, LE ;
CLEMMONS, DR ;
GULER, HP ;
BACH, MA ;
SKARULIS, M .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (07) :593-601
[4]  
CAVANAGH J, 1995, PROTEIN NMR SPECTROS
[5]   SOLUTION STRUCTURE OF HUMAN INSULIN-LIKE GROWTH FACTOR-I - A NUCLEAR-MAGNETIC-RESONANCE AND RESTRAINED MOLECULAR-DYNAMICS STUDY [J].
COOKE, RM ;
HARVEY, TS ;
CAMPBELL, ID .
BIOCHEMISTRY, 1991, 30 (22) :5484-5491
[6]   Design, synthesis and binding affinities of novel non-peptide mimics of somatostatin/sandostatin(R) [J].
Damour, D ;
Barreau, M ;
Blanchard, JC ;
Burgevin, MC ;
Doble, A ;
Herman, F ;
Pantel, G ;
JamesSurcouf, E ;
Vuilhorgne, M ;
Mignani, S ;
Poitout, L ;
LeMerrer, Y ;
Depezay, JC .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (14) :1667-1672
[7]   Convergent solutions to binding at a protein-protein interface [J].
DeLano, WL ;
Ultsch, MH ;
de Vos, AM ;
Wells, JA .
SCIENCE, 2000, 287 (5456) :1279-1283
[8]   Peptide exosite inhibitors of factor VIIa as anticoagulants [J].
Dennis, MS ;
Eigenbrot, C ;
Skelton, NJ ;
Ultsch, MH ;
Santell, L ;
Dwyer, MA ;
O'Connell, MP ;
Lazarus, RA .
NATURE, 2000, 404 (6777) :465-470
[9]  
DeWolf E, 1996, PROTEIN SCI, V5, P2193
[10]   Binding protein-3-selective insulin-like growth factor I variants:: Engineering, biodistributions, and clearance [J].
Dubaquié, Y ;
Mortensen, DL ;
Intintoli, A ;
Hogue, DA ;
Nakamura, G ;
Rancatore, P ;
Lester, P ;
Sadick, MD ;
Filvaroff, E ;
Fielder, PJ ;
Lowman, HB .
ENDOCRINOLOGY, 2001, 142 (01) :165-173